Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 8/20 | 0.73 |
| ▸ | CA12 | O43570 | 5/20 | 0.68 |
| ▸ | CA7 | P43166 | 5/20 | 0.68 |
| ▸ | CA9 | Q16790 | 5/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.68 |
| ▸ | CA1 | P00915 | 4/20 | 0.68 |
| ▸ | CA2 | P00918 | 2/20 | 0.68 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.63 |
| ▸ | CA4 | P22748 | 3/20 | 0.62 |
| ▸ | CA6 | P23280 | 3/20 | 0.62 |
| ▸ | CA5A | P35218 | 3/20 | 0.62 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.62 |
| ▸ | MET | P08581 | 1/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | MAOB | P27338 | 1/20 | 0.58 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28116687 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL27864031 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL19359006 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL27658775 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL28126782 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL19359004 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL10299697 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL30946730 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL6397881 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL7771767 | 1.00 | APP (0.73) | APPCA12CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3713604-B1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPABILITY | LEIBNIZ INST FUER NEUROBIOLOGIE LIN STIFTUNG DES OEFFENTLICHEN RECHTS (DE) | 2023-06-07 | — | — | EP | claimed |
| EP-3713604-A1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPABILITY | Leibniz-institut Für Neurobiologie (lin) Stiftung (DE) | 2020-09-30 | — | — | EP | claimed |
| WO-2019101952-A1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPABILITY | Leibniz-Institut für Neurobiologie (LIN) Stiftung des Öffentlichen Rechts (DE) | 2019-05-31 | — | — | WO | claimed |
| US-20250195550-A1 | A NOVEL NUTRACEUTICAL/THERAPEUTICAL COMPOSITION OF CINNAMIC ACID DERIVATIVES WITH SUCROSE ISOMERS | FERTIS INDIA PVT. LTD. (IN) | 2025-06-19 | — | — | US | disclosed |
| EP-3713604-B1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPABILITY | LEIBNIZ INST FUER NEUROBIOLOGIE LIN STIFTUNG DES OEFFENTLICHEN RECHTS (DE) | 2023-06-07 | — | — | EP | disclosed |
| US-20200360332-A1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPACITY | LEIBNIZ-INSTITUT FUER NEUROBIOLOGIE (LIN) STIFTUNG DES OEFFENTLICHEN RECHTS (DE) | 2020-11-19 | — | — | US | disclosed |
| EP-3713604-A1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPABILITY | Leibniz-institut Für Neurobiologie (lin) Stiftung (DE) | 2020-09-30 | — | — | EP | disclosed |
| WO-2019101952-A1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPABILITY | Leibniz-Institut für Neurobiologie (LIN) Stiftung des Öffentlichen Rechts (DE) | 2019-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200360332-A1 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPACITY | DBH, OR51E2, ACHE | APP 1974/4885CA12 4033/4885CA7 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.